Skip to content
MedsAcross

Medicine

Fenofibrate 43 mg capsule

Fenofibrate · Oral
Available on requestPrescription onlyUS FDAGeneric name

Fenofibrate 43 mg capsule is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…

Key facts

Active ingredient (INN)
Fenofibrate
Brand
Sold under the generic name
Strength
43 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 30 capsules and 2 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaLupinIndiaApotex
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) in a tightly closed container.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C10AB05 Fenofibrate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
22 February 2013
Identifiers
RxCUI 483425, 483427DailyMed set ID 68024459-987a-9cf4-f539-4959093bc9f0, 16ea8ce4-8c1c-4111-509e-86aa688d89a0, 37b25526-0bd0-4459-a4be-f3a6893506f9NDC 60505-3120, 55111-349, 68180-130Application ANDA202252, ANDA090859, NDA021695

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle55111-349-01Dr. Reddy's LaboratoriesIndia7 April 2014
30 capsule in 1 bottle55111-349-30Dr. Reddy's LaboratoriesIndia7 April 2014
30 capsule in 1 bottle68180-130-06LupinIndia22 February 2013
100 capsule in 1 bottle60505-3120-1Apotex26 July 2013
30 capsule in 1 bottle60505-3120-3Apotex26 July 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Fenofibrate 43 mg capsule.

Compare 1

Other strengths and forms of Fenofibrate

Clinical summary

Fenofibrate is a peroxisome proliferator receptor alpha agonist indicated as adjunctive therapy to diet. It is available as tablets and capsules for oral use. MedsAcross supplies Fenofibrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Fenofibrate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Fenofibrate 43 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.